Panacea Biotec Pharma Limited Paclitaxel Export Data — India (DGFT 2022–2026)

Name: Panacea Biotec Pharma Limited Paclitaxel Export Records India — #5 Exporter, 65 Shipments, $3.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Paclitaxel

India Pharmaceutical Trade Intelligence

$83.1M319 Suppliers142 CountriesHS 30049044

ExportsIndia → GERMANY20.6%India → UNITED STATES13.1%

ImportsSOUTH KOREA → India$1.6B UNITED STATES → India$2.3M

#1 Supplier: FRESENIUS KABI #1 Buyer: FRESENIUS KABI

Panacea Biotec Pharma Limited — Paclitaxel Exporter #5 | $3.3M Trade Value | TransData Nexus | TransData Nexus

Panacea Biotec Pharma Limited — Paclitaxel Exporter Profile

Indian Pharmaceutical Exporter · #5 for Paclitaxel · $3.3M export value · DGFT Verified

Panacea Biotec Pharma Limited is the #5 Indian exporter of Paclitaxel with $3.3M in export value and 65 verified shipments. Panacea Biotec Pharma Limited holds a 3.9% market share in Paclitaxel exports across 15 countries. The company exports 13 pharmaceutical products worth $23.9M across 9 therapeutic categories.

Panacea Biotec Pharma Limited — Paclitaxel Export Profile: Buyers & Destinations

Panacea Biotec Pharma Limited Paclitaxel export treemap — buyers and destination countries | TransData Nexus

Where Does Panacea Biotec Pharma Limited Export Paclitaxel?

Country	Value	Shipments	Share
CANADA	$1.8M	39	79.1%
LATVIA	$150.0K	3	6.6%
TURKEY	$88.3K	2	3.9%
HONDURAS	$50.0K	1	2.2%
SRI LANKA	$46.7K	5

Who Are the Top Buyers of Paclitaxel from Panacea Biotec Pharma Limited?

Buyer	Country	Value	Orders
APOTEX CORP	CANADA	$700.0K	14
APOTEX INC.	CANADA	$600.0K	12
APOTEX INC	CANADA	$450.0K	9
M S AGENCIAS Y REPRESENTACIONES HO NDUTECS A DE CV	HONDURAS	$50.0K	1
SIA MAGNIPHARMA	LATVIA	$50.0K	1
APOTEX INC - SIGNET	CANADA	$50.0K	1
SIA "MAGNIPHARMA"	LATVIA	$50.0K	1
SIA " MAGNIPHARMA	LATVIA	$50.0K	1
BA PHARMA TRADING LTD	TURKEY	$44.5K	1
BA PHARMA TRADING LTD,	TURKEY	$43.9K	1

Panacea Biotec Pharma Limited supplies Paclitaxel to 28 buyers globally. The largest buyer is APOTEX CORP (CANADA), followed by APOTEX INC. (CANADA) and APOTEX INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Paclitaxel Formulations Does Panacea Biotec Pharma Limited Export?

Product Description / Formulation	Value	Shipments
PACLITAXEL PROTEIN-BOUND P ARTICLE / ODS / PRODUCT / ITEM FORINJECTABLE SUSPENSION 100 MG B/N 907023010 907023011 M/D.09/2023 E/D.08/2025 B	$100.0K	2
PACLITAXEL ( PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) B/N.907024024 M/D.01/2025 E/D.12/2026.	$100.0K	2
PACLIALL PACLITAXEL (PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION) (LYOPHILIZED POWDER FOR SUSPENSION FOR INFUSION	$69.4K	2
PACLIALL PACLITAXEL PROTEIN BOUND P ARTICLE / ODS / PRODUCT / ITEM FOR INJECTABLE SUSPENSION LYOPHILIZED POWDER FOR SUSPENSION FOR INFUSION	$65.0K	3
PACLIALL PACLITAXEL (PROTEIN BOUND PARTICLES FOR INJECTABLE SUSPENSION) (LYOPHILIZED POWDER FOR SUSPENSION FOR INFUSION	$64.0K	3
PACLITAXEL PROTEIN BOUND P ARTICLE / ODS / PRODUCT / ITEM FOR	$50.0K	1
PACLITAXEL (PROTEIN BOUND PARTICLES FOR	$50.0K	1
PACLITAXEL PROTEIN-BOUND P ARTICLE / ODS / PRODUCT / ITEM FORINJECTABLE SUSPENSION 100 MG 907023014M/D.10/2023 E/D.09/2025	$50.0K	1
PACLITAXEL PROTEIN-BOUND P ARTICLE / ODS / PRODUCT / ITEM FORINJECTABLE SUSPENSION 100 MG B/N.907023012 M/D.10/2023 E/D.09/2025.	$50.0K	1
PACLITAXEL (PROTEIN-BOUND PARTICLES FORINJECTABLE SUSPENSION 100 MG) 907023016M/D.12/2023 E/D.11/2025VLS	$50.0K	1

Panacea Biotec Pharma Limited exports 55 distinct Paclitaxel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PACLITAXEL PROTEIN-BOUND P ARTICLE / ODS / PRODUCT / ITEM FO with 2 shipments worth $100.0K.

How Does Panacea Biotec Pharma Limited Compare to Nearest Paclitaxel Exporters?

Exporters ranked immediately above and below #5 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	MSN LABORATORIES PRIVATE LIMITED	$6.9M	138	2	$50.0K
3	INTAS PHARMACEUTICALS LIMITED	$5.9M	405	19	$14.7K
5	PANACEA BIOTEC PHARMA LIMITED ★	$3.3M	65	15	$50.0K
6	VENUS REMEDIES LIMITED	$3.2M	220	18	$14.4K
4	JODAS EXPOIM PRIVATE LIMITED	$3.1M	63	2	$50.0K

Panacea Biotec Pharma Limited ranks #5 among 319 Indian Paclitaxel exporters. Average shipment value of $50.0K compared to the market average of $192.6K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Paclitaxel Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	830	16.8%
SAHAR AIR	614	12.5%
DELHI AIR	599	12.2%
SAHAR AIR CARGO ACC (INBOM4)	554	11.2%
HYDERABAD AIR	186	3.8%
AHEMDABAD AIR	183	3.7%
Bombay Air	172	3.5%
HYDERABAD ACC (INHYD4)	160	3.2%

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Paclitaxel Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Panacea Biotec. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential delays. These maritime disruptions are particularly concerning for time-sensitive pharmaceutical shipments, as extended transit times and congestion elevate the risk of cold-chain failures for vaccines and biologics. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced uncertainties for Indian exporters. While health products have been exempt from U.S. tariffs, there is growing concern that this exemption may not be permanent. The potential imposition of tariffs on pharmaceutical imports could impact Panacea Biotec's profitability, given the company's significant export volume to the U.S. market. (lemonde.fr)

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture market share previously held by Chinese manufacturers. This shift presents an opportunity for Panacea Biotec to expand its footprint in the U.S. market, provided it can navigate the evolving regulatory and trade environment effectively.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. The recent GMP non-compliance issue at Panacea Biotec's Baddi facility underscores the importance of adhering to stringent EU regulations. Addressing these compliance challenges promptly is essential to maintain and grow the company's presence in European markets.

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency (EMA) enforcing stringent quality standards. For Indian exporters, maintaining compliance with these standards is paramount to ensure uninterrupted market access.

Panacea Biotec's recent GMP non-compliance at its Baddi facility highlights the critical need for robust quality management systems. The company has committed to implementing comprehensive corrective and preventive actions and plans to request a re-inspection to reinstate its GMP certificates. (prysm.fi) Proactive measures in quality assurance will be vital for Panacea Biotec to rebuild trust with regulatory bodies and international clients.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Paclitaxel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Panacea Biotec Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 65 individual customs records matching Panacea Biotec Pharma Limited exporting Paclitaxel, covering 55 formulations to 16 countries via 28 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 142+ countries, 959+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Paclitaxel

Paclitaxel

Panacea Biotec Pharma Limited — Paclitaxel Exporter Profile

Panacea Biotec Pharma Limited — Paclitaxel Export Profile: Buyers & Destinations

Where Does Panacea Biotec Pharma Limited Export Paclitaxel?

Who Are the Top Buyers of Paclitaxel from Panacea Biotec Pharma Limited?

What Is India's Total Paclitaxel Export Value and How Much Does Panacea Biotec Pharma Limited Contribute?

What Is the Average Shipment Value for Panacea Biotec Pharma Limited's Paclitaxel Exports?

How Does Panacea Biotec Pharma Limited Compare to Other Indian Paclitaxel Exporters?

What Paclitaxel Formulations Does Panacea Biotec Pharma Limited Export?

Regulatory Requirements: Exporting Paclitaxel to Key Markets

Canada — HC

How Does Panacea Biotec Pharma Limited Compare to Nearest Paclitaxel Exporters?

Which Indian Ports Ship Paclitaxel Exports?

Paclitaxel — Export Intelligence Video

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Paclitaxel Exports

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

About Panacea Biotec Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Paclitaxel Export Data from Panacea Biotec Pharma Limited

Paclitaxel Stats

Company Overview

Top Products by Panacea Biotec Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source